Highmark Commercial Medical Policy - Pennsylvania |
Medical Policy: | S-172-014 |
Topic: | Ovarian and Internal Iliac Vein Embolization as Treatment for Pelvic Congestion Syndrome |
Section: | Surgery |
Effective Date: | September 18, 2017 |
Issue Date: | July 23, 2018 |
Last Reviewed: | July 2018 |
Pelvic congestion syndrome (PCS also known as pelvic venous incompetence (PVI) is a condition that has been present for greater than 6 months with anatomic findings that include pelvic venous insufficiency and pelvic varicosities. The technique of transcatheter embolization for ovarian and pelvic varices is a minimally invasive treatment usually performed by an interventional radiologist that involves selective catheterization of the ovarian and internal iliac veins, followed by contrast venography and embolization. |
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.
Policy Position Coverage is subject to the specific terms of the member’s benefit plan. |
Ovarian and internal iliac vein embolization as treatment for pelvic congestion syndrome is considered experimental/investigational, and therefore non-covered. The published data regarding embolization therapy for pelvic congestion syndrome are inadequate to permit scientific conclusions, due to the lack of standardized diagnostic criteria for pelvic congestion and the lack of controlled trials of embolization therapy.
Place of Service: Inpatient/Outpatient |
Ovarian and Internal Iliac Vein Embolization as Treatment for Pelvic Congestion Syndrome is typically an outpatient procedure which is only eligible for coverage as an inpatient procedure in special circumstances, including, but not limited to, the presence of a co-morbid condition that would require monitoring in a more controlled environment such as the inpatient setting.
The policy position applies to all commercial lines of business |
Denial Statements |
Services that do not meet the criteria of this policy will be considered experimental/investigational (E/I). A network provider can bill the member for the experimental/investigational service. The provider must give advance written notice informing the member that the service has been deemed E/I. The member must be provided with an estimate of the cost and the member must agree in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.
Links |